141 related articles for article (PubMed ID: 31243519)
1. UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis.
Locri F; Dal Monte M; Aronsson M; Cammalleri M; De Rosa M; Pavone V; Kvanta A; Bagnoli P; André H
J Mol Med (Berl); 2019 Sep; 97(9):1273-1283. PubMed ID: 31243519
[TBL] [Abstract][Full Text] [Related]
2. Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.
Locri F; Pesce NA; Aronsson M; Cammalleri M; De Rosa M; Pavone V; Bagnoli P; Kvanta A; Dal Monte M; André H
J Mol Med (Berl); 2020 Nov; 98(11):1629-1638. PubMed ID: 32940719
[TBL] [Abstract][Full Text] [Related]
3. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.
Dal Monte M; Rezzola S; Cammalleri M; Belleri M; Locri F; Morbidelli L; Corsini M; Paganini G; Semeraro F; Cancarini A; Rusciano D; Presta M; Bagnoli P
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2392-407. PubMed ID: 25766585
[TBL] [Abstract][Full Text] [Related]
5. Mitigation of human iris angiogenesis through uPAR/LRP-1 interaction antagonism in an organotypic ex vivo model.
Pesce NA; Plastino F; Reyes-Goya C; Bernd J; Pavone V; Dal Monte M; Kvanta A; Locri F; André H
FASEB J; 2024 Mar; 38(5):e23533. PubMed ID: 38451430
[TBL] [Abstract][Full Text] [Related]
6. UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency.
Carriero MV; Bifulco K; Minopoli M; Lista L; Maglio O; Mele L; Di Carluccio G; De Rosa M; Pavone V
Mol Cancer Ther; 2014 May; 13(5):1092-104. PubMed ID: 24705350
[TBL] [Abstract][Full Text] [Related]
7. Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its induction.
Pe'er J; Neufeld M; Baras M; Gnessin H; Itin A; Keshet E
Ophthalmology; 1997 Aug; 104(8):1251-8. PubMed ID: 9261311
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal aflibercept for rubeosis iridis secondary to proliferative diabetic retinopathy.
Weng SW; Huang TL; Su PY; Chang PY; Wang JK
Eye Sci; 2015 Dec; 30(4):201-3. PubMed ID: 27215012
[TBL] [Abstract][Full Text] [Related]
9. Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis.
Locri F; Aronsson M; Beaujean O; Kvanta A; André H
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29578513
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs, VEGF, and Proinflammatory Cytokines.
Gilcy GK; Kuttan G
Integr Cancer Ther; 2016 Dec; 15(4):NP1-NP12. PubMed ID: 27146127
[TBL] [Abstract][Full Text] [Related]
11. Effect of squalamine on iris neovascularization in monkeys.
Genaidy M; Kazi AA; Peyman GA; Passos-Machado E; Farahat HG; Williams JI; Holroyd KJ; Blake DA
Retina; 2002 Dec; 22(6):772-8. PubMed ID: 12476105
[TBL] [Abstract][Full Text] [Related]
12. Rabbit rubeosis iridis induced by intravitreal latex-derived angiogenic fraction.
Paula JS; Ribeiro VR; Sampaio RB; Mendonca RJ; Haddad A; Tedesco AC; Coutinho-Netto J; Haendchen HA; Jorge R
Curr Eye Res; 2011 Sep; 36(9):857-9. PubMed ID: 21599469
[TBL] [Abstract][Full Text] [Related]
13. Anterior segment ischemia with rubeosis iridis after a circular buckling operation treated successfully with an intravitreal bevacizumab injection: a case report and review of the literature.
Janssens K; Zeyen T; Van Calster J
Bull Soc Belge Ophtalmol; 2012; (319):5-9. PubMed ID: 22550771
[TBL] [Abstract][Full Text] [Related]
14. [Morphological study of rubeosis iridis induced in animal eyes].
Nishikawa M; Ito S; Tokura T; Yamane A; Miki H
Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):447-54. PubMed ID: 1377866
[TBL] [Abstract][Full Text] [Related]
15. [Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion].
Kabesha TB; Glacet-Bernard A; Rostaqui O; Souied EH
J Fr Ophtalmol; 2015 May; 38(5):414-20. PubMed ID: 25956562
[TBL] [Abstract][Full Text] [Related]
16. A novel in vivo model of puncture-induced iris neovascularization.
Beaujean O; Locri F; Aronsson M; Kvanta A; André H
PLoS One; 2017; 12(6):e0180235. PubMed ID: 28658313
[TBL] [Abstract][Full Text] [Related]
17. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
18. [Effect of pan-retinal photocoagulation in iris neovascularization].
Nishikawa M; Ito S; Tokura T; Yamane A; Miki H
Nippon Ganka Gakkai Zasshi; 1992 Sep; 96(9):1085-92. PubMed ID: 1384289
[TBL] [Abstract][Full Text] [Related]
19. Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery.
Barile GR; Chang S; Horowitz JD; Reppucci VS; Schiff WM; Wong DT
Am J Ophthalmol; 1998 Sep; 126(3):379-89. PubMed ID: 9744371
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.
Rezzola S; Corsini M; Chiodelli P; Cancarini A; Nawaz IM; Coltrini D; Mitola S; Ronca R; Belleri M; Lista L; Rusciano D; De Rosa M; Pavone V; Semeraro F; Presta M
Diabetologia; 2017 Apr; 60(4):719-728. PubMed ID: 28083635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
